The potential for further increase in the pps is g
Post# of 8751
Electrome's withdrawal of their 510(k) could indicate a shift towards leveraging Biel's existing regulatory pathway and branding, suggesting a potential licensing or OEM deal.
Biel is involved in contract manufacturing, indicating that they may be working on PEMF devices for others.
The global PEMF therapy devices market is growing, which may create opportunities for collaboration between these companies.
Overall, while there is no definitive confirmation, the strategic moves and market conditions suggest a likelihood of collaboration between Electrome and Biel in the PEMF device sector.